For six patients in Berlin whose bodies had resisted every advanced treatment medicine could offer, a single infusion of genetically reprogrammed immune cells has opened a door that years of failed therapies had kept shut. Researchers at Charité - Universitätsmedizin Berlin have applied CAR T-cell therapy — long a tool of oncology — to severe rheumatoid arthritis, coaxing the immune system not merely into silence but into something resembling renewal. Three of the six participants entered sustained, medication-free remission, raising a quiet but profound question: what if the immune system, gi
Cancer Therapy Shows Promise in Severe Rheumatoid Arthritis, Achieving Remission in Early Trial
Six patients with severe treatment-resistant rheumatoid arthritis experienced marked disease reduction, with three achieving medication-free remission and improved quality of life.